A Provider May Consider Testing for CYP2D6 Variants Prior to Starting

question 6

Multiple Choice

A provider may consider testing for CYP2D6 variants prior to starting tamoxifen for breast cancer to:

• A) Ensure the patient will not have increased adverse drug reactions to the tamoxifen
• B) Identify potential drug-drug interactions that may occur with tamoxifen
• C) Reduce the likelihood of therapeutic failure with tamoxifen treatment
• D) Identify poor metabolizers of tamoxifen

---

Definitions:

Brand Development Index

A measure of a brand's market strength within a specific geography or demographic, calculated as a ratio of the brand's market share to the population share within that segment.

Market Segments

Divisions within a market categorized by distinct characteristics, needs, or preferences, allowing for targeted marketing strategies.

BDI

Brand Development Index, a measure of a brand's sales performance within a specific market or demographic group, compared to its overall performance.

Market Segment

A group of individuals or organizations sharing one or more characteristics, making them have similar product needs.